ctrl K

Price Alert

Relay Therapeutics Inc. (RLAY)

NASDAQ: RLAY · Real-Time Price · USD

4.01

-0.06 (-1.47%)

At close: Sep 10, 2025, 1:36 PM

Relay Therapeutics Revenue Breakdown

Period Ending	Jun 30, 2025
Operating Segments Revenue	677K
Operating Segments Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	13.63M	18.74M	16.9M	19.75M	18.77M	18.4M	16.77M	18.48M	20.12M	19.58M	16.37M	16.07M	17.46M	16.07M	15.55M	14.68M	14.42M	12.73M	15.54M	12.23M	6.05M	4.76M	3.43M	3.65M	3.51M	3.07M
Selling, General, and Administrative Revenue Growth	-27.28%	+10.86%	-14.41%	+5.22%	+1.99%	+9.77%	-9.30%	-8.13%	+2.76%	+19.60%	+1.85%	-7.96%	+8.69%	+3.35%	+5.89%	+1.80%	+13.25%	-18.07%	+27.08%	+102.07%	+27.22%	+38.88%	-6.19%	+4.10%	+14.38%	n/a
Research and Development Revenue	63.9M	73.81M	68.08M	76.62M	91.99M	82.4M	77.5M	81.49M	88.2M	82.83M	67.28M	66.9M	60.51M	51.67M	51.91M	44.97M	45.15M	30.62M	32.12M	24.38M	21.67M	21.7M	22.41M	18.26M	16.4M	13.34M
Research and Development Revenue Growth	-13.43%	+8.42%	-11.15%	-16.71%	+11.64%	+6.33%	-4.91%	-7.60%	+6.49%	+23.11%	+0.56%	+10.56%	+17.12%	-0.46%	+15.42%	-0.38%	+47.43%	-4.67%	+31.78%	+12.51%	-0.16%	-3.16%	+22.74%	+11.34%	+22.96%	n/a